Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Delaware for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Delaware only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Delaware (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Yvan Maque Acosta (NPI 1306252648)

Field	Value
Entity Type	Individual
Organization	Yvan Maque Acosta
Address	1100 Forrest Ave
City	Dover
State	DE
ZIP	19904
Taxonomy	Rheumatology Physician
NPI Enumerated	July 8, 2014

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider’s Medicare business is heavily centered on infused or injected biologic therapies consistent with a rheumatology practice: the top revenue codes are J0129 (abatacept), J0897 (denosumab), and J0717 (certolizumab pegol), and the top 3 Medicare codes by revenue account for 69.5% of total Medicare revenue, indicating a service-line focused on administration of specialty injectable agents. The presence of multiple high-revenue drug administration codes (J1602, J1745, J3111) alongside chemotherapy administration codes (96401, 96413, 96415) further suggests substantial infusion/medication administration operations rather than a pure office-based visit mix.

Revenue concentration is pronounced: total Medicare revenue is $1.3M and nearly 70% of that income is attributable to the top three codes, meaning a small set of biologic injections drives most Medicare revenue; by contrast this provider has no Medicaid billing on file, so its public-payer footprint is effectively single-payer Medicare.

The provider’s payer mix is highly skewed toward Medicare — $1.3M in lifetime Medicare revenue versus no Medicaid billing reported — making the entity effectively single-payer from the available public-pay records and exposing revenue to utilization patterns and reimbursement changes for these Medicare-covered injectable drugs.

Competitive standing varies by code: for J0897 the provider ranks #475 of 10057 (95th percentile), a notably above-typical national volume and signaling a relatively prominent role nationally in administering denosumab; for J0129 and J0717 the provider sits in the middle percentiles (65th and 68th), indicating typical, unremarkable national volumes for abatacept and certolizumab pegol.

Operational throughput includes substantive office evaluation-and-management activity but at much smaller revenue impact compared with drug administration: 99214 and 99213 together account for a small share of Medicare revenue ($33.9K and $22.3K respectively), reflecting that visits support but do not dominate the business model which is drug-administration centric.

Tenure in Medicare is long-standing: the NPI was enumerated on 2014-07-08 (about 12 years ago), indicating an established presence in Medicare billing and suggesting the revenue pattern reflects a mature practice rather than a short-term or newly established operation.

There are targeted high-volume administration codes where the provider’s activity is unusually concentrated relative to peers: J0897 is described as 'notably above typical national volume' and the provider’s rank in the 95th percentile confirms this code is a standout in their profile, whereas several other injectable codes are described as 'typical, unremarkable volume' indicating selective specialization rather than uniformly high utilization across all biologics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	11,030	$30	$374.9K
J0897	Injection, denosumab, 1 mg	15,780	$20	$284K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	66,800	$1	$267.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	10,500	$10	$115.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3,460	$30	$90K
J3111	Injection, romosozumab-aqqg, 1 mg	8,190	$10	$65.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	370	$90	$33.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	410	$60	$23.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	350	$60	$22.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	180	$100	$18.8K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Delaware Distribution

Yvan Maque Acosta — 0 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Delaware

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	5	10	11,030	$30	$432.5K
J0717	8	10	98,800	$1	$376.8K
J3111	6	10	29,930	$10	$245K
J1602	6	10	21,050	$10	$238.8K
J1745	6	10	3,610	$30	$134.3K
J0897	7	60	3,360	$20	$132.9K
96413	16	30	280	$100	$36.6K
99214	463	1,830	150	$80	$25.5K
96401	9	30	110	$60	$18.4K
99213	321	1,810	120	$60	$13.6K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Yvan Maque Acosta, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jinsong Zhang	DE	Rheumatology Physician	$3.5M	$0
Robert Moyer	DE	Rheumatology Physician	$1.3M	$0
Infusion Solutions Of Delaware	DE	Specialist	$0	$410K
Surjeet Dheer	DE	Rheumatology Physician	$382.7K	$0
Taras Yurchenko	DE	Medical Physician Assistant	$317.3K	$0

Nearby Providers

Other providers in the same ZIP code as Yvan Maque Acosta, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bayada Home Health Care, Inc.	DE	Home Health Agency	$0	$37.9M
At Home Infucare, LLC	DE	Home Health Agency	$0	$28.5M
Amazing Home Care Agency	DE	Home Health Agency	$0	$18.7M
Dedicated To Women Ob-gyn, P.A.	DE	Obstetrics & Gynecology Physician	$0	$11.1M
Help At Home Of Delaware, LLC	DE	In Home Supportive Care Agency	$0	$10.7M
A Center For Mental Wellness, Inc.	DE	Mental Health Counselor	$0	$9.9M
State Of Delaware	DE	Case Management Agency	$0	$9.2M
West Dover Dental, LLC	DE	Dentist	$0	$9M
Americare Home Solutions	DE	In Home Supportive Care Agency	$0	$8.4M
Vicdania Health Services LLC	DE	Home Health Agency	$0	$7.4M

Yvan Maque Acosta — Billing Profile & Reimbursement Data

Sign up for Yvan Maque Acosta — Billing Profile & Reimbursement Data policy alerts

Yvan Maque Acosta — Billing Profile & Reimbursement Data

Sign up for Yvan Maque Acosta — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References